ABBISKO-B: Next Day Disclosure Return
Apr 26 10:16 ET
ABBISKO-B: VOLUNTARY ANNOUNCEMENT - FGFR4 INHIBITOR IRPAGRATINIB GRANTED ODD BY FDA
Apr 24 19:36 ET
ABBISKO-B: Next Day Disclosure Return
Apr 24 10:08 ET
ABBISKO-B: RESIGNATION OF JOINT COMPANY SECRETARY
Apr 24 08:50 ET
ABBISKO-B: Next Day Disclosure Return
Apr 23 08:22 ET
ABBISKO-B: Next Day Disclosure Return
Apr 22 08:57 ET
ABBISKO-B: Next Day Disclosure Return
Apr 19 08:22 ET
ABBISKO-B: Next Day Disclosure Return
Apr 18 10:35 ET
ABBISKO-B: Next Day Disclosure Return
Apr 17 10:08 ET
ABBISKO-B: Next Day Disclosure Return
Apr 16 18:46 ET
ABBISKO-B: Notification Letter and Reply Form to Registered Shareholders
Apr 16 04:36 ET
ABBISKO-B: Notification Letter and Reply Form to Non-registered Shareholders
Apr 16 04:35 ET
ABBISKO-B: FORM OF PROXY FOR THE 2023 ANNUAL GENERAL MEETING
Apr 16 04:34 ET
ABBISKO-B: NOTICE OF THE ANNUAL GENERAL MEETING
Apr 16 04:33 ET
ABBISKO-B: PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES RE-ELECTION OF DIRECTORS RE-APPOINTMENT OF AUDITOR PROPOSED AMENDMENTS TO THE NINTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE TENT
Apr 16 04:32 ET
ABBISKO-B: 2023 Environmental, Social and Governance Report
Apr 16 04:31 ET
ABBISKO-B: 2023 Annual Report
Apr 16 04:30 ET
ABBISKO-B: Next Day Disclosure Return
Apr 15 09:51 ET
ABBISKO-B: Next Day Disclosure Return
Apr 12 08:30 ET
ABBISKO-B: Next Day Disclosure Return
Apr 11 08:42 ET
No Data
No Data